← Leaderboards
Michael F Grunebaum
Columbia University Health Sciences
$5,425,154
Attributed
$5,425,154
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $607K · FY2006–22$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,425,154 · 3
By mechanism
R01$4,541,009 · 2
K23$884,145 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Edward V Nunes$88,947,598
- Richard W Foltin$21,307,956
- Frances Rudnick Levin$39,078,718
- Marian W Fischman$5,515,675
- Sarah H Lisanby$7,610,671
Others in their field
Top investigators on “Suicidal Behavior”
- Robert J. Ursano · Henry M. Jackson Fdn For The Adv Mil/Med$42,497,358
- David A. Brent · University Of Pittsburgh At Pittsburgh$30,087,618
- Robert A Hummer · Univ Of North Carolina Chapel Hill$28,336,705
- Joseph J Mann · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc$27,891,616
- Boris Birmaher · University Of Pittsburgh At Pittsburgh$25,355,585
- Murray B. Stein · University Of California, San Diego$22,696,471
Research focus
Suicidal BehaviorSuicide AttemptSuicidePharmaceutical PreparationsSuicidalSuicide PreventionDouble-Blind MethodAntidepressive AgentsClinical TrialsFeeling SuicidalSuicidal RiskDepressed MoodMental DepressionHigh RiskRandomizedMajor Depressive DisorderResponseMoodsDepression And SuicideCause Of DeathBupropionSamplingChronicAnesthetics
Grant awards (14)
IM Ketamine for rapid reduction of suicidal thoughts in high-risk emergency room patients: a midazolam-controlled trial$575,915
R01 · FY2022 · MH · contact PI
IM Ketamine for rapid reduction of suicidal thoughts in high-risk emergency room patients: a midazolam-controlled trial$575,727
R01 · FY2021 · MH · contact PI
IM Ketamine for rapid reduction of suicidal thoughts in high-risk emergency room patients: a midazolam-controlled trial$607,024
R01 · FY2020 · MH · contact PI
Ketamine vs Midazolam: Testing Rapid Relief of Suicide Risk in Depression$586,167
R01 · FY2016 · MH · contact PI
Ketamine vs Midazolam: Testing Rapid Relief of Suicide Risk in Depression$501,596
R01 · FY2015 · MH · contact PI
Ketamine vs Midazolam: Testing Rapid Relief of Suicide Risk in Depression$77,427
R01 · FY2015 · MH · contact PI
Ketamine vs Midazolam: Testing Rapid Relief of Suicide Risk in Depression$527,065
R01 · FY2014 · MH · contact PI
Ketamine vs Midazolam: Testing Rapid Relief of Suicide Risk in Depression$505,984
R01 · FY2013 · MH · contact PI
Ketamine vs Midazolam: Testing Rapid Relief of Suicide Risk in Depression$584,104
R01 · FY2012 · MH · contact PI
Paroxetine/Bupropion in Suicide Attempters/Ideators with Major Depression$176,861
K23 · FY2010 · MH · contact PI
Paroxetine/Bupropion in Suicide Attempters/Ideators with Major Depression$176,861
K23 · FY2009 · MH · contact PI
Fluoxetine Versus Bupropion in Suicide Attempters With Major Depressive Disorder$176,861
K23 · FY2008 · MH · contact PI
Fluoxetine Versus Bupropion in Suicide Attempters With Major Depressive Disorder$176,861
K23 · FY2007 · MH · contact PI
Fluoxetine/Bupropion Suicide Attempters Major Depressive$176,701
K23 · FY2006 · MH · contact PI